| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Adjuvant immunotherapy for cancer: the next step
|
Sondak, Vernon K
|
|
2015
|
16 |
5 |
p. 478-480
3 p.
|
artikel
|
| 2 |
Adjuvant ipilimumab versus placebo after complete resection of high-risk stage III melanoma (EORTC 18071): a randomised, double-blind, phase 3 trial
|
Eggermont, Alexander M M
|
|
2015
|
16 |
5 |
p. 522-530
9 p.
|
artikel
|
| 3 |
Afatinib versus methotrexate as second-line treatment in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck progressing on or after platinum-based therapy (LUX-Head & Neck 1): an open-label, randomised phase 3 trial
|
Machiels, Jean-Pascal H
|
|
2015
|
16 |
5 |
p. 583-594
12 p.
|
artikel
|
| 4 |
BRAF and CDKN2A mutations in secondary high-grade glioma
|
Boughton, Barbara
|
|
2015
|
16 |
5 |
p. e201-
1 p.
|
artikel
|
| 5 |
BRCA1 and BRCA2 mutation type associated with cancer risk
|
Burki, Talha Khan
|
|
2015
|
16 |
5 |
p. e205-
1 p.
|
artikel
|
| 6 |
BRCA2 variant aerodigestive cancer risk
|
Gruber, Karl
|
|
2015
|
16 |
5 |
p. e204-
1 p.
|
artikel
|
| 7 |
Cancer immunotherapy: enthusiasm and reality aligning at last
|
The Lancet Oncology,
|
|
2015
|
16 |
5 |
p. 475-
1 p.
|
artikel
|
| 8 |
Carcinogenicity of tetrachlorvinphos, parathion, malathion, diazinon, and glyphosate
|
Guyton, Kathryn Z
|
|
2015
|
16 |
5 |
p. 490-491
2 p.
|
artikel
|
| 9 |
Circulating tumour DNA and CT monitoring in patients with untreated diffuse large B-cell lymphoma: a correlative biomarker study
|
Roschewski, Mark
|
|
2015
|
16 |
5 |
p. 541-549
9 p.
|
artikel
|
| 10 |
Correction to Lancet Oncol 2015; 16: 545
|
|
|
2015
|
16 |
5 |
p. e199-
1 p.
|
artikel
|
| 11 |
Correction to Lancet Oncol 2015; 16: 447, 448
|
|
|
2015
|
16 |
5 |
p. e199-
1 p.
|
artikel
|
| 12 |
Correction to Lancet Oncol 2015; 16: e163
|
|
|
2015
|
16 |
5 |
p. e199-
1 p.
|
artikel
|
| 13 |
Correction to Lancet Oncol 2013; 14: e374
|
|
|
2015
|
16 |
5 |
p. e199-
1 p.
|
artikel
|
| 14 |
Effect of enzalutamide on health-related quality of life, pain, and skeletal-related events in asymptomatic and minimally symptomatic, chemotherapy-naive patients with metastatic castration-resistant prostate cancer (PREVAIL): results from a randomised, phase 3 trial
|
Loriot, Yohann
|
|
2015
|
16 |
5 |
p. 509-521
13 p.
|
artikel
|
| 15 |
EGFR inhibition for recurrent or metastatic HNSCC
|
Argiris, Athanassios
|
|
2015
|
16 |
5 |
p. 488-489
2 p.
|
artikel
|
| 16 |
High-quality cancer diagnosis for resource-poor locations
|
Maurice, John
|
|
2015
|
16 |
5 |
p. e205-
1 p.
|
artikel
|
| 17 |
Ibrutinib in pretreated Waldenström's macroglobulinaemia
|
Bagcchi, Sanjeet
|
|
2015
|
16 |
5 |
p. e204-
1 p.
|
artikel
|
| 18 |
Including children in life-sustaining treatment decisions
|
Bagcchi, Sanjeet
|
|
2015
|
16 |
5 |
p. e202-
1 p.
|
artikel
|
| 19 |
Increasing morbidity in childhood-onset cancer survivors
|
Tanday, Sanjay
|
|
2015
|
16 |
5 |
p. e202-
1 p.
|
artikel
|
| 20 |
Increasing prevalence of euthanasia in Belgium
|
Burki, Talha Khan
|
|
2015
|
16 |
5 |
p. e200-
1 p.
|
artikel
|
| 21 |
India launches air quality index to tackle pollution problems
|
Tanday, Sanjay
|
|
2015
|
16 |
5 |
p. e203-
1 p.
|
artikel
|
| 22 |
Large B-cell lymphoma: is the future written in the blood?
|
Dawson, Sarah-Jane
|
|
2015
|
16 |
5 |
p. 481-483
3 p.
|
artikel
|
| 23 |
Little Stars
|
Burki, Talha Khan
|
|
2015
|
16 |
5 |
p. 495-
1 p.
|
artikel
|
| 24 |
Mobile medicine
|
Howe, Rhiannon
|
|
2015
|
16 |
5 |
p. 497-
1 p.
|
artikel
|
| 25 |
Mogamulizumab benefits seen in cutaneous T-cell lymphoma
|
Tanday, Sanjay
|
|
2015
|
16 |
5 |
p. e200-
1 p.
|
artikel
|
| 26 |
Molecular subgroups of atypical teratoid rhabdoid tumours in children: an integrated genomic and clinicopathological analysis
|
Torchia, Jonathon
|
|
2015
|
16 |
5 |
p. 569-582
14 p.
|
artikel
|
| 27 |
Next generation prophylactic human papillomavirus vaccines
|
Schiller, John T
|
|
2015
|
16 |
5 |
p. e217-e225
nvt p.
|
artikel
|
| 28 |
NICE guidance on pomalidomide for relapsed and refractory multiple myeloma previously treated with lenalidomide and bortezomib
|
Burke, Martyn J
|
|
2015
|
16 |
5 |
p. 492-493
2 p.
|
artikel
|
| 29 |
Nilotinib, imatinib, and GIST therapy
|
del Muro, Xavier Garcia
|
|
2015
|
16 |
5 |
p. 483-484
2 p.
|
artikel
|
| 30 |
Nilotinib versus imatinib as first-line therapy for patients with unresectable or metastatic gastrointestinal stromal tumours (ENESTg1): a randomised phase 3 trial
|
Blay, Jean-Yves
|
|
2015
|
16 |
5 |
p. 550-560
11 p.
|
artikel
|
| 31 |
Ombrabulin plus cisplatin versus placebo plus cisplatin in patients with advanced soft-tissue sarcomas after failure of anthracycline and ifosfamide chemotherapy: a randomised, double-blind, placebo-controlled, phase 3 trial
|
Blay, Jean-Yves
|
|
2015
|
16 |
5 |
p. 531-540
10 p.
|
artikel
|
| 32 |
Overtreatment of younger patients with colon cancer
|
Burki, Talha Khan
|
|
2015
|
16 |
5 |
p. e203-
1 p.
|
artikel
|
| 33 |
Patient-related outcomes for metastatic prostate cancer
|
Basch, Ethan
|
|
2015
|
16 |
5 |
p. 477-478
2 p.
|
artikel
|
| 34 |
Pazopanib plus weekly paclitaxel versus weekly paclitaxel alone for platinum-resistant or platinum-refractory advanced ovarian cancer (MITO 11): a randomised, open-label, phase 2 trial
|
Pignata, Sandro
|
|
2015
|
16 |
5 |
p. 561-568
8 p.
|
artikel
|
| 35 |
PET-adapted salvage therapy for Hodgkin's lymphoma
|
Laffon, Eric
|
|
2015
|
16 |
5 |
p. e197-e198
nvt p.
|
artikel
|
| 36 |
PET-adapted salvage therapy for Hodgkin's lymphoma – Authors' reply
|
Schöder, Heiko
|
|
2015
|
16 |
5 |
p. e198-
1 p.
|
artikel
|
| 37 |
Present status of human papillomavirus vaccine development and implementation
|
Herrero, Rolando
|
|
2015
|
16 |
5 |
p. e206-e216
nvt p.
|
artikel
|
| 38 |
Primary endpoints for future prophylactic human papillomavirus vaccine trials: towards infection and immunobridging
|
Lowy, Douglas R
|
|
2015
|
16 |
5 |
p. e226-e233
nvt p.
|
artikel
|
| 39 |
Programmed cell death-1 inhibition in lymphoma
|
Hawkes, Eliza A
|
|
2015
|
16 |
5 |
p. e234-e245
nvt p.
|
artikel
|
| 40 |
p53: The Gene That Cracked The Cancer Code
|
Ranscombe, Peter
|
|
2015
|
16 |
5 |
p. 496-
1 p.
|
artikel
|
| 41 |
Radiotherapy for elderly patients with low-risk breast cancer
|
Kaidar-Person, Orit
|
|
2015
|
16 |
5 |
p. e196-e197
nvt p.
|
artikel
|
| 42 |
Ramucirumab versus placebo in combination with second-line FOLFIRI in patients with metastatic colorectal carcinoma that progressed during or after first-line therapy with bevacizumab, oxaliplatin, and a fluoropyrimidine (RAISE): a randomised, double-blind, multicentre, phase 3 study
|
Tabernero, Josep
|
|
2015
|
16 |
5 |
p. 499-508
10 p.
|
artikel
|
| 43 |
Recalibrating emergency care in the UK: pulling our weight
|
O'Leary, Ben
|
|
2015
|
16 |
5 |
p. e195-
1 p.
|
artikel
|
| 44 |
Second-line therapy for metastatic colorectal cancer
|
Price, Timothy J
|
|
2015
|
16 |
5 |
p. 476-477
2 p.
|
artikel
|
| 45 |
Should patients with melanoma brain metastases receive adjuvant whole-brain radiotherapy?
|
Fogarty, Gerald B
|
|
2015
|
16 |
5 |
p. e195-e196
nvt p.
|
artikel
|
| 46 |
Stem-cell transplantation increases fracture risk
|
Bagcchi, Sanjeet
|
|
2015
|
16 |
5 |
p. e201-
1 p.
|
artikel
|
| 47 |
Tackling cancer control in the Gulf Cooperation Council Countries
|
Al-Othman, Saleh
|
|
2015
|
16 |
5 |
p. e246-e257
nvt p.
|
artikel
|
| 48 |
Targeting the microenvironment in ovarian cancer
|
Lheureux, Stephanie
|
|
2015
|
16 |
5 |
p. 485-486
2 p.
|
artikel
|
| 49 |
Terminal cancer: a happy ending?
|
Coburn, Cassandra
|
|
2015
|
16 |
5 |
p. 498-
1 p.
|
artikel
|
| 50 |
68th Annual Cancer Symposium of the Society of Surgical Oncology
|
Collingridge, David
|
|
2015
|
16 |
5 |
p. 494-
1 p.
|
artikel
|
| 51 |
Towards risk-adapted therapy for rhabdoid tumour subgroups
|
Hoffman, Lindsey M
|
|
2015
|
16 |
5 |
p. 486-488
3 p.
|
artikel
|
| 52 |
Tumour vascular-disrupting agents in soft-tissue sarcoma
|
Quek, Richard
|
|
2015
|
16 |
5 |
p. 480-481
2 p.
|
artikel
|
Tijdschrift beschrijving